Biodesix (BDSX) Other Non-Current Liabilities (2019 - 2026)

Biodesix has reported Other Non-Current Liabilities for 8 years, with the latest figure at $860000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 24.28% year-over-year to $860000.0; the trailing twelve-month figure through Mar 2026 stood at $860000.0 (up 24.28% YoY), and the FY2025 full-year result was $1.0 million, up 25.28% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $860000.0, down from $1.0 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $18.6 million in Q4 2022, with the low at $60000.0 in Q3 2022.
• Historically, Other Non-Current Liabilities has averaged $3.6 million across 5 years, with a median of $744000.0 in 2024.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities tumbled 99.7% — and 2023, when it surged 17475.71%.
• Biodesix's Other Non-Current Liabilities stood at $18.6 million in 2022, then sank by 96.18% to $712000.0 in 2023, then gained by 14.47% to $815000.0 in 2024, then rose by 25.28% to $1.0 million in 2025, then slipped by 15.77% to $860000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $860000.0 (Q1 2026), $1.0 million (Q4 2025), and $769000.0 (Q3 2025), per Business Quant data.